Skip to content
10-Q

Quarterly Report

Evolutionary Genomics, Inc.

0001553350-21-000646

← back to feed
Filed
Aug 6, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jun 30, 2021 5.88M sh
Long Term Debt Q2 2021 · Jun 30, 2021 $2.32M
Long Term Debt Q2 2021 · Dec 31, 2020 $2.25M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $588
Cash And Equivalents Q2 2021 · Dec 31, 2020 $215.84K
Cash And Equivalents Q2 2021 · Jun 30, 2020 $2.45K
Cash And Equivalents Q2 2021 · Dec 31, 2019 $45.44K
Current Liabilities Q2 2021 · Jun 30, 2021 $129.23K
Current Liabilities Q2 2021 · Dec 31, 2020 $3.16K
Total Liabilities Q2 2021 · Jun 30, 2021 $2.45M
Total Liabilities Q2 2021 · Dec 31, 2020 $2.25M
Current Assets Q2 2021 · Jun 30, 2021 $41.88K
Current Assets Q2 2021 · Dec 31, 2020 $277.59K
Total Assets Q2 2021 · Jun 30, 2021 $3.24M
Total Assets Q2 2021 · Dec 31, 2020 $3.99M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$267.26K
Stockholders Equity Q2 2021 · Jun 30, 2020 −$760.48K
Stockholders Equity Q2 2021 · Mar 31, 2020 −$520.61K
Stockholders Equity Q2 2021 · Dec 31, 2019 −$333.73K
Sga Expense Q2 2021 · Jun 30, 2020 $49.84K
Sga Expense Q2 2021 · Jun 30, 2020 $106.51K
Rd Expense Q2 2021 · Jun 30, 2020 $167.53K
Rd Expense Q2 2021 · Jun 30, 2020 $260.75K
Net Income Q2 2021 · Jun 30, 2020 −$294.8K
Net Income Q2 2021 · Jun 30, 2020 −$536.61K
Operating Income Q2 2021 · Jun 30, 2020 −$310.6K
Operating Income Q2 2021 · Jun 30, 2020 −$540.41K
Revenue Q2 2021 · Jun 30, 2020 $12.5K